ethaverine has been researched along with Coronary Disease in 2 studies
ethaverine: tetraethyl homolog of papaverine; smooth muscle relaxant; RN given refers to parent cpd; structure
Coronary Disease: An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
MOON, D | 1 |
MINEUR, HJ | 1 |
HOPPER, GR | 1 |
SCHWARTZ, SH | 1 |
Lacroix, P | 1 |
Linee, P | 1 |
Le Polles, JB | 1 |
2 other studies available for ethaverine and Coronary Disease
Article | Year |
---|---|
Ballistocardiographic studies of ethaverine as a coronary vasodilator; preliminary report.
Topics: Ballistocardiography; Cardiovascular Agents; Coronary Disease; Humans; Muscle Relaxants, Central; Pa | 1954 |
Effects of some coronary vasodilator drugs on collateral hemodynamics after chronic myocardial ischemia in the anesthetized dog: appropriate or inappropriate redistribution?
Topics: Animals; Chromonar; Coronary Circulation; Coronary Disease; Coronary Vessels; Dipyridamole; Dogs; Fe | 1978 |